FT

J&J vaccine shows 66% efficacy for moderate and severe Covid-19

US pharmaceutical group says it will soon seek emergency authorisation for one-shot jab

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button